RT Journal Article
SR Electronic
T1 THE EFFECT OF A VASOCONSTRICTIVE AGENT, METARAMINOL, ON HUMAN TOLERANCE TO ACCELERATION
JF Journal of Pharmacology and Experimental Therapeutics
JO J Pharmacol Exp Ther
FD American Society for Pharmacology and Experimental Therapeutics
SP 228
OP 231
VO 117
IS 2
A1 Greiner, Theodore
YR 1956
UL http://jpet.aspetjournals.org/content/117/2/228.abstract
AB Metaraminol in oral doses of 1 mgm. per kgm. increased tolerance to positive acceleration an average of 0.7 g-unit in 8 volunteers tested on the human centrifuge. This protection was far below that provided by the G-suit or by gradual induction of acceleration. Combination of metaraminol with either of these two systems provided no additional advantage.